Arterial hypertension and cognitive impairment in elderly and senile patients: basic approaches to patient management
DOI: https://dx.doi.org/10.18565/pharmateca.2024.1.52-61
Ostroumova O.D., Telkova S.S., Dzamihov K.K., Kochetkov A.I., Baronov S.A.
1) Russian Medical Academy of Continuous Professional Education, Moscow, Russia;
2) I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia;
3) N.A. Semashko National Research Institute of Public Health, Moscow, Russia
The development and progression of cognitive impairment (CI), including dementia, are an important medical and social problem, especially in the context of increasing life expectancy and «aging» of the population. Arterial hypertension (AH) is a significant modifiable risk factor for development of CI. Antihypertension therapy is considered as the main proven method of preventing cognitive disorders. According to the information presented in this literature review, dihydropyridine calcium antagonists and diuretics are the most effective classes of antihypertension drugs with cerebroprotective effect, not only due to the long-term and stable maintenance of blood pressure within the target values, but also due to additional specific mechanisms. In this regard, these groups of drugs can be considered as first-line therapy for the prevention of CI in elderly and senile people with AH. Such representatives of calcium antagonists and diuretics as nitrendipine and indapamide, respectively, have the greatest evidence base for the presence of neuroprotective mechanisms.
About the Autors
Corresponding author: Olga D. Ostroumova, Dr. Sci, (Med.), Professor, Head of the Department of Therapy and Polymorbid Pathology n.a. Acad.
M.S. Vovsi, Russian Medical Academy of Continuous Professional Education; Professor at the Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia; ostroumova.olga@mail.ru
Similar Articles